In vitro susceptibility patterns of clinically important Trichophyton and Epidermophyton species against nine antifungal drugs

Hamid Badali, Rasoul Mohammadi, Olga Mashedi, G Sybren de Hoog, Jacques F Meis

    Research output: Contribution to journal/periodicalArticleScientificpeer-review

    Abstract

    Despite the common, worldwide, occurrence of dermatophytes, little information is available regarding susceptibility profiles against currently available and novel antifungal agents. A collection of sixty-eight clinical Trichophyton species and Epidermophyton floccosum were previously identified and verified to the species level by sequencing the internal transcribed spacer (ITS) regions of rDNA. MICs of amphotericin B, fluconazole, itraconazole, voriconazole, posaconazole, isavuconazole, terbinafine and MECs of caspofungin and anidulafungin were performed based on CLSI M38-A2. The resulting MIC90 s of all strains were, in increasing order, as follows: terbinafine (0.063 mg l(-1) ); posaconazole (1 mg l(-1) ); isavuconazole and anidulafungin (2 mg l(-1) ); itraconazole, voriconazole, amphotericin B, and caspofungin (4 mg l(-1) ) and fluconazole (>64 mg l(-1) ). These results confirm that terbinafine is an excellent agent for treatment of dermatophytosis due to T. rubrum, T. mentagrophytes, T. verrucosum, T. schoenleinii and E. floccosum. In addition, the new azoles POS and ISA are potentially useful antifungals to treat dermatophytosis. However, the clinical effectiveness of these novel antifungals remains to be determined.

    Original languageEnglish
    Pages (from-to)303-7
    Number of pages5
    JournalMycoses
    Volume58
    Issue number5
    DOIs
    Publication statusPublished - May 2015

    Fingerprint

    Dive into the research topics of 'In vitro susceptibility patterns of clinically important Trichophyton and Epidermophyton species against nine antifungal drugs'. Together they form a unique fingerprint.

    Cite this